PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Medimix International

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Medimix CEO Named to Top 100 Most Influential People in Pharma - Henry Gazay, CEO of Medimix International and VoxMedTM, was named one of the 100 most influential people in the life sciences industry, selected by PharmaVoice readers for his vision in market research and passion for innovation
Medimix CEO Named to Top 100 Most Influential People in Pharma

 

NewswireToday - /newswire/ - Miami, FL, United States, 2011/09/02 - Henry Gazay, CEO of Medimix International and VoxMedTM, was named one of the 100 most influential people in the life sciences industry, selected by PharmaVoice readers for his vision in market research and passion for innovation.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Medimix International announced that Henry Gazay, CEO of Medimix International and VoxMedTM, has been named as one of the 100 most influential people in the life sciences industry. He was nominated and selected by PharmaVoice readers for his vision in the area of market research and his passion for innovation.

“The PharmaVOICE 100 are individuals in the life-sciences industry who are ”navigating the bumps and curves of today’s road to industry success, with fearless confidence and inventive maneuvering”…..”who think outside the box, pioneer new paths to success, and inspire their colleagues in the industry," said Taren Grom, editor-in-chief and cofounder of PharmaVOICE.

A serial entrepreneur and global marketing expert with 20-plus years’ experience, Henry has pioneered online market research in the pharma, biotech, and medical device sectors. He has developed new techniques, such as electronic patient charts, global on-line discussion forums, continuous trackers, and social media monitoring.

In February, 2011, after three years of intense development, he launched VoxMedTM, the first social media community for healthcare professionals around the world. VoxMedTM helps them connect with their peers in a secure and verified platform, engage each other on timely subjects, self-publish articles, share information, and engage with stakeholders in their industry.

“It is through years of perseverance, hard work and commitment to our clients that I owe this recognition,” commented Henry. “Through the dedication and leadership of every loyal member of Medimix, we have made our company a respected player in a very competitive field.”

A regular speaker at various conferences in Europe, US, Asia and Latin America, Henry is also a board member of Pharmaceutical Business Intelligence Research Group, and actively involved In EphMRA, PMRG, and ESOMAR.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Medimix International

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Medimix CEO Named to Top 100 Most Influential People in Pharma

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Kathryn McAdam - Medimix.net 
305-573-5233 kmcadam[.]medimix.net
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Medimix International securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Medimix International / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan
GE Healthcare Acquires Asymptote for Complete, Digitally-enabled Cryogenic Cold Chain Technology Supporting Safe Manufacture And Delivery Of Cellular
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil
GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare
Next-generation Natural Materials to Replace Traditional Synthetic Materials in Personal Care Products Finds Frost & Sullivan
Digital Innovation-driven Diagnostic Advances Transform Smart Healthcare Finds Frost & Sullivan
Hospitals’ Outsourcing of Sterile Processing Expand Opportunities for Third Party Service Providers in the US & Western Europe Finds Frost & Sullivan
Emerging Cardiac Therapies Catalysed by Innovative Product and Next-generation Technology Finds Frost & Sullivan
Austrian Centre of Industrial Biotechnology and GE Healthcare Establish A Cell Line Engineering Collaboration
Sequencing Platform Providers Aim to Develop Tests for Infectious Diseases to Expand Market Opportunity Finds Frost & Sullivan
Arcadia Wins Top Honors from Frost & Sullivan for its Next-generation Clinical and Claims Analytics Platform, Arcadia Analytics
Vendors Favour Platform Monitoring as Novel Service Models Disrupt APAC Home Health Monitoring Market Finds Frost & Sullivan
Leader Biomedical and Urogyn Collaborate to Bring Innovative New Procedure Urolastic™ to India
Emergency Service Partners Joins US Acute Care Solutions
Thriving Healthcare Markets in Asia and Latin America Offer Strong Growth Opportunities for Global Players Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)